CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
S R JavedSimon R LordS El BadriR HarmanJ HolmesF KamziTimothy S MaughanDavid McIntoshS MukherjeeA OomsG RadhakrishnaP ShawMaria A HawkinsPublished in: British journal of cancer (2023)
EU Clinical Trials Register (EudraCT) - 2015-003965-27 ClinicalTrials.gov - NCT03641547.